Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure

Journal of Endocrinological Investigation

Volumn 21, Issue 3, 1998, Pages 170-179

  Clerico, A ^a   Iervasi, G ^a   Del Chicca, M G ^a   Emdin, M ^a   Maffei, S ^a   Nannipieri, M ^a   Sabatino, L ^a   Forini, F ^a   Manfredi, C ^a   Donato, L ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

ANP; BNP; Cardiac diseases; Heart failure; IRMA; Natriuretic peptides; RIA

Indexed keywords

APROTININ; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; EDETIC ACID; IODINE 125; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CHROMATOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HORMONE BLOOD LEVEL; HUMAN; IMMUNORADIOMETRIC ASSAY; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MALE; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; SYMPTOM; VENOUS BLOOD;

EID: 15444361735     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347297     Document Type: Article

References (41)

1. De Bold A.J. Atrial natriuretic factor: A hormone produced by the heart. Science 230: 767, 1985.
2. Ruskoaho H. Atrial natriuretic peptide: Synthesis, release, and metabolism. Pharmacol. Rev. 44: 479,1992.
3. De Zeeuw D., Janssen W.M.T., De Jong P.E. Atrial natriuretic factor: its (patho)physiological significance in humans. Kidney Int. 41: 1115, 1992.
4. Espiner E.A Hormones of the cardiovascular system. In: Ed. 3. DeGroot L.J. (Ed.), Endocrinology. W.B. Saunders Company, USA, 1995, p. 2895.
5. Francis G.S., Benedict C., Johnstone D.E., Kirlin P.C., Nicklas J., Liang C., et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 82: 1724, 1990.
6. Swedberg K., Eneroth P., Kjekshus J., Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 82: 1730, 1990.
7. Clerico A., Iervasi G. Alterations in metabolic clearance of atrial natriuretic peptides in heart failure: How do they relate to the resistance to atrial natriuretic peptides? J. Cardiac Failure 1: 323, 1995.
8. Arakawa N., Nakamura M., Aoki H., Hiramori K. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. Am. Coll. Cardiol. 27: 1656, 1996.
9. Omland T., Aakvaag A., Bonarjee V.V.S., Caidahl K., Terje Lie R., Nilsen D.W.T., Sundsfjord J.A., Dickstein K. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and n-terminal proatrial natruretic peptide. Circulation 93: 1963, 1996.
10. Clerico A., Del Chicca M.G., Giganti M., Zucchelli G.C., Piffanelli A. Evaluation and comparison of the analytical performances of two RIA kits for the assay of atrial natriuretic peptides (ANP). J. Nucl. Med. All. Sci. 34: 81, 1990.
11. Clerico A., Opocher G., Pelizzola D., Panzali A.F., Andreone P., Del Chicca M.G., Giganti M., Zucchelli C.G., Mantero F., Albertini A., Piffanelli A. Evaluation of the analytical performance of RIA methods for measurement of Atrial Natriuretic Peptides (ANP): A multicentre study. J. Clin. Immunoassay 14: 251, 1991.
12. Clerico A., Iervasi G., Del Chicca M.G., Maffei S., Berti S., Sabatino L., Turchi S., Cazzuola F., Manfredi C., Biagini A. Analytical performance and clinical usefulness of a commercially available IRMA kit for the measurement of atrial natriuretic peptide in patients with heart failure. Clin. Chem. 42: 1627, 1996.
13. Gutkowska J., Genest J., Thibault G., Garcia R., Larochelle P., Cusson J.R., Kuchel O., Hamet P., De Léean A., Cantin M. Circulating forms and radioimmunoassay of atrial natriuretic factor. Endocrinol. Metab. Clin. North Am. 16: 183, 1987.
14. Yandle T.G., Espiner E.A., Nicholls M.G., Duff H. Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma. J. Clin. Endocrinol. Metab. 63: 72, 1986.
15. Kato J., Kida O., Kita T., Nakamura S., Sasaki A., Kodama K., Tanaka K. Free and bound forms of atrial natriuretic peptide (ANP) in rat plasma: Preferential increase of free ANP in spontaneously hypertensive rats (SHR) and strokeprone SHR (SHRSP). Biochem. Biophys. Res. Commun. 153: 1084, 1988.
16. Itoh H., Nakao K., Sugawara A., Saito Y., Mukoyama M., Morii N., Yamada T., Shiono S., Arai H., Hosoda K., Imura H. Atrial natriuretic polypeptide (gamma-ANP)-derived peptides in human plasma: Cosecretion of N-terminal gamma-ANP fragment and alpha-ANP. J. Clin. Endocrinol. Metab. 67: 429, 1988.
17. Gutkowska J., Bourassa M., Roy D., Thibault G., Garcia R., Cantin M., Genest J. Immunoreactive atrial natriuretic factor (IR-ANF) in human plasma. Biochem. Biophys. Res. Commun. 128: 1350, 1985.
18. Ohashi M., Fujio N., Nawata H., Kato K.I., Ibayashi H., Kangawa K., Matsuo H. High plasma concentrations of human atrial natriuretic polypeptide in aged men. J. Clin. Endocrinol. Metab. 64: 81, 1987.
19. Richards A.M., Tonolo G., McIntyre G.D., Leckie B.J., Robertson I. Radio-immunoassay for plasma alpha human atrial natriuretic peptide; a comparison of direct and preextracted method. J. Hypertens. 5: 227, 1987.
20. Polesi C., Rodella A., Mantero G., Cannella G., Ferrari R., Albertini A. Improved radioimmunoassay of atrial natriuretic peptide in plasma. Clin. Chem. 35: 1431, 1989.
21. Yandle T.G., Richards A.M., Gilbert A., Fisher S., Holmes S., Espiner E.A. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J. Clin. Endocrinol. Metab. 76: 832, 1993.
22. Davidson N.C., Naas A.A., Hanson J.K., Kennedy N.S.J., Coutie W.J., Struthers A.D. Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and n-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am. J. Cardiol. 77: 828, 1996.
23. Lewis H.M., Ratcliffe W.A., Stott R.A.W., Wilkins M.R., Baylis P.H. Development and validation of a two-site immunoradiometric assay for human atrial natriuretic factor in unextracted plasma. Clin. Chem. 35: 953, 1989.
24. Tattersal J.E., Dawnay A., McLean C., Cattel W.R. Immunoradiometric assay of atrial natriuretic peptide in unextracted plasma. Clin. Chem. 36: 885, 1990.
25. Tsuji T., Masuda H., Imagawa K., Haraikawa M., Shibata K., Kono M., Inouye K., Uchida K. Stability of human atrial natriuretic peptide in blood samples. Clin. Chim. Acta 225: 171, 1994.
26. Kono M., Yamauchi A., Tsuji T., Misaka A., Igano K., Ueki K., Fusjishima M., Ueda A., Inouye K., Imura H. An immunoradiometric assay for brain natriuretic peptide in human plasma. Kaku Igaku 13: 2, 1993.
27. Iervasi G., Clerico A., Berti S., Pilo A., Vitek F., Biagini A., Baratto M.T., Bianchi R., Donato L. ANP kinetics in normal men: in vivo measurement by a tracer method and correlation with sodium intake. Am. J. Physiol. 264: F480, 1993.
28. Clerico A., Iervasi G., Berti S., Pilo A., Vitek F., Salvadori S., Marastoni M., Manfredi C., Del Chicca M.G., Iascone M.R., Biagini A. In vivo measurement of ANP overall turnover and identification of its main metabolic pathways under steady state conditions in humans. J. Endocrinol. Invest. 18: 194, 1995.
29. Iervasi G., Clerico A., Berti S., Pilo A., Biagini A., Bianchi R., Donato L. Altered tissue degradation and distribution of Atrial Natriuretic Peptide in patients with idiopathic dilated cardiomyopathy and its relationship with clinical severity of the disease and sodium handling. Circulation 91: 2018, 1995.
30. Pilo A., Zucchelli G.C., Malvano R., Masini S. Main features of computer algorithms for RIA data reduction. Comparison of some different approaches for the interpolation of dose-response curve. J. Nucl. Med. All. Sci. 26: 235, 1982.
31. Herbers J.E. Jr., Noel G.L. Diagnostic tests and clinical decisions. In: Moore W.T., Eastman E.C. (Eds.), Diagnostic Endocrinology, ed. 2. Mosby, St Louis, 1996, p. 1.
32. Clarkson P.M.B., Wheeldom N.M., MacFadyen R.J., Pringle S.D., MacDonald T.M. Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure. Circulation 93: 2037, 1966.
33. Yoshibayashi M., Saito Y., Nakao K. Brain natriuretic peptide versus atrial natriuretic peptide - physiological and pathophysiological significance in children and adults: A review. Eur. J. Endocrinol. 135: 265, 1966.
34. Omland T., Aakvaag A., Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart 76: 232, 1996.
35. Struthers A.D. Plasma concentrations of brain natriuretic peptide: will this new test reduce the need for cardiac investigations? Br. Heart J. 70: 397, 1993.
36. Yamamoto K., Burnett J.C. Jr., Jougasaki M., Nishimura R.A., Bailey K.R., Saito Y., Nakao K., Redfield M.M. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 28: 988, 1996.
37. Cowie M.R., Struthers A.D., Wood D.A., Coats A.J.S., Thompson S.G., Poole-Wiulson P.A., Sutton G.C. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350: 1349, 1997.
38. Clerico A., Iervasi G. Immunoassay methods for the measurement of natriuretic cardiac hormones (ANP, BNP, and related peptides) in humans. Clinical Chemistry (in press).
39. Yoshimura M., Yashue H., Okumura K., Ogawa H., Jougasaki M., Mukoyama M., Nakao K., Imura H. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 87: 464, 1993.
40. Yasue H., Yoshimura M., Sumida H., Kikuta K., Kugiyama K., Jougasaki M., Ogawa H., Okumura K., Mukoyama M., Nakao K. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90: 195, 1994.
41. Hunt P.J., Espiner E.A., Nicholls M.G., Richards A.M., Yandle T.G. Differing biological effects of equimolar atrial and brain natriuretic peptide infusion in normal man. J. Clin. Endocrinol. Metab. 81: 3871, 1996.